Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemical lumbar sympathectomy

D I Hughes-Davies, L R Redman

    Anaesthesia
    |October 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Chemical lumbar sympathectomy provided pain relief for many elderly patients with peripheral arteriosclerotic disease, reducing amputation rates. Younger patients and those with diabetic ischemic disease saw less benefit, suggesting alternative treatments may be preferable.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Chemical lumbar sympathectomy with radiological assessment.

    Annals of the Royal College of Surgeons of England·2009
    Same author

    A nerve palsy occurring during the recovery period.

    Anaesthesia·1987
    Same author

    An improved ultra-violet halothane meter.

    British journal of anaesthesia·1980
    Same author

    An automatic interference refractometer.

    British journal of anaesthesia·1978
    Same author

    Hypothenar muscle action potential recorder.

    Biomedical engineering·1976
    Same author

    A system for minimizing respiratory heat loss in infants during operation.

    Anesthesia and analgesia·1973
    Same journal

    Pulmonary artery catheters or central venous catheters for cardiac surgery: the PUMA Pilot randomised clinical trial.

    Anaesthesia·2026
    Same journal

    Opioid-free vs. opioid-inclusive anaesthesia with or without regional anaesthesia for postoperative pain.

    Anaesthesia·2026
    Same journal

    Optimal dose of intra-operative dexmedetomidine for postoperative delirium prevention: a reply.

    Anaesthesia·2026
    Same journal

    Optimal dose of intra-operative dexmedetomidine for postoperative delirium prevention.

    Anaesthesia·2026
    Same journal

    Pain control or brain protection with esketamine: a reply.

    Anaesthesia·2026
    Same journal

    A step forward for patient-centred fasting guidelines: a reply.

    Anaesthesia·2026
    See all related articles

    Area of Science:

    • Vascular Surgery
    • Interventional Radiology
    • Pain Management

    Background:

    • Peripheral arteriosclerotic disease and diabetic ischemic disease can lead to severe pain and amputation.
    • Chemical lumbar sympathectomy is a minimally invasive procedure to interrupt sympathetic nerve function.

    Purpose of the Study:

    • To describe the technique and outcomes of chemical lumbar sympathectomy.
    • To evaluate the efficacy of this procedure in different patient populations.

    Main Methods:

    • A series of 124 chemical lumbar sympathectomies were performed on 97 patients.
    • Patients were stratified by age and underlying condition (peripheral arteriosclerotic disease or diabetic ischemic disease).

    Main Results:

    Related Experiment Videos

  • In 68 elderly patients (>60 years) with peripheral arteriosclerotic disease, 52 experienced pain relief, with only one requiring amputation.
  • In 16 younger patients (<60 years) with peripheral arteriosclerotic disease, 10 benefited, but other treatments are recommended.
  • In 13 elderly patients with diabetic ischemic disease, 6 benefited, suggesting it can help prevent amputation.

    • Conclusions:

    • Chemical lumbar sympathectomy is effective for pain relief and amputation prevention in elderly patients with peripheral arteriosclerotic disease.
    • The procedure offers benefits for some elderly patients with diabetic ischemic disease.
    • Alternative treatments should be considered for younger patients with peripheral arteriosclerotic disease.